Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases

European Journal of Nuclear Medicine

Volumn 24, Issue 2, 1997, Pages 143-149

  Staudenherz, Anton ^a   Abela, Claudette ^b   Niederle, Bruno ^b   Steiner, Erich ^c   Helbich, Thomas ^c   Puig, Stefan ^c   Kaserer, Klaus ^d   Becherer, Alexander ^a   Leitha, Thomas ^a   Kletter, Kurt ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b University Clinic of General Surgery   (Austria)

^c Radiology Clinic   (Austria)

^d Clinical Institute of Pathology   (Austria)

Author keywords

Primary hyperparathyroidism; Technetium 99m sestamibi dual phase study; Technetium 99m subtraction scintigraphy; Thallium 201; Thyroid disease; Uptake mechanisms

Indexed keywords

CALCIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; OSTEOCALCIN; PERTECHNETIC ACID TC 99M; THALLIUM 201;

ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL TRIAL; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PARATHYROID ADENOMA; PARATHYROID GLAND; PARATHYROID SCINTISCANNING; PREOPERATIVE EVALUATION; PREVALENCE; PRIMARY HYPERPARATHYROIDISM; PROSPECTIVE STUDY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID DISEASE;

EID: 8044260814     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02439546     Document Type: Article

References (31)

1. Niederle B, Roka R, Fritsch A. Long-term results after surgical treatment of primary hyperparathyroidism. Prog Surg 1986; 18: 146-164.
2. Casas AT, Burke GJ, Mansberger AR, Wie JP. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism. Am Surg 1994, 60: 12-16.
3. Wie JP, Burke GJ. Analysis of savings in operative time for primary hyperparathyroidism using localization with technetium 99m sestamibi scan. Am J Surg 1995; 170: 488-491.
4. 201Tl-chloride in a parathyroid adenoma. Clin Nucl Med 1979; 4: 229-230.
5. Ferlin G, Bursato N, Camerani M, Conte N, Zotti D. New perspectives in localizing enlarged parathyroid glands by technetium-thallium subtraction scan. J Nucl Med 1983; 24: 438-441.
6. Young AE, Gaunt JI, Groft DN, Collins REC, Wells CP, Coakley AJ. Location of parathyroid adenomas by thallium-201 and technetium-99m subtraction scanning. Br Med J 1983; 286: 1384-1386.
7. Hauty M, Swatz, K, McClung M et al. Technetium-thallium scintiscanning for the localization of parathyroid adenomas and hyperplasia; a reappraisal. Am J Surg 1987; 153: 479-486.
8. Taillefer R, Boucher Y, Potvin C, Lambert R. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992; 33: 1801-1807.
9. Johnston LB, Carroll MJ, Britton KE, Lowe DG, Shand W, Besser GM, Grossman AB. The accuracy of parathyroid gland localization in primary hyperparathyroidism using sestamibi radionuclide imaging. J Clin Endocrinol Metab 1996; 81: 346-352.
10. Jones AG, Abrams MJ, Davison A, Brodack JW, Toothaker AK, Adelstein SJ, Kassis AI. Biological studies of a new class of technetium complexes: the hexakis(alkylisonitrile)technetium(I) cations. Int J Nucl Med Biol 1984; 11: 225-234.
11. Kronauge JF, Chiu ML, Cone JS, Davison A, Holman BL, Jones AG, Piwnica-Worms D. Comparison of neutral and cationic myocardial perfusion agents, characteristics of accumulation in cultured cells. Nucl Med Biol 1992; 19: 141-148.
12. Chernoff DM, Strichartz GR, Piwnica-Worms D. Membrane potential determination in large unilamellar vesicles with hexakis(2-methoxyisobutylisonitrile)technetium(I). Biochem Biophys Acta 1993; 1147: 262-266.
13. Chiu ML, Kronange JF, Piwnica-Worms D. Effect of mitochondrial and plasma-membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium in cultured mouse fibroblasts. J Nucl Med 1990; 31: 1646-1653.
14. Sandrock D, Merino MJ, Norton JA, Neumann RD. Ultrastructural histology correlates with results of thallium-201/technetium-99m parathyroid subtraction scintigraphy. J Nucl Med 1993; 34: 24-29.
15. Bénard F, Lefebvre B, Beuvon F, Langlois MF, Bisson G. Rapid washout of technetium-99m-MIBI from a large parathyroid adenoma. J Nucl Med 1995; 36: 241-243
16. Altenähr E. The parathyroid glands. In: Johannessen JV, ed. Electron microscopy in human medicine, vol 10. New York: McGraw-Hill; 1981: 111-146.
17. Weibl E. Stereological methods I and II. London: Academic press, 1979
18. Okerlund MD, Sheldon K, Corpus S, et al. A new method with high sensitivity and specificity for localization for abnormal parathyroid glands. Ann Surg 1984; 200: 381-388.
19. Basarab RM, Manni A, Harrison TS. Dual isotope subtraction parathyroid scintigraphy in the preoperative evaluation of suspect hyperparathyroidism. Clin Nucl Med 1985; 10: 300-314.
20. Sandrock D, Merino MJ, Norton JA, Neumann RD. Parathyroid imaging by Tc/Tl scintigraphy. Eur J Nucl Med 1990; 16: 607-613.
21. Coakley AJ. Parathyroid imaging. Nucl Med Commun 1995; 16: 522-533.
22. McBiles M, Lambert AT, Cote MG, Kim SY. Sestamibi parathyroid imaging. Semin Nucl Med 1995; 25: 221-234.
23. Staudenherz A, Telfeyan D, Steiner E, Niederle B, Leitha T, Kletter K. Scintigraphic pitfall in giant parathyroid glands. J Nucl Med 1995; 36: 467-469.
24. Chan TYK, Serpell JW, Chan O, Gaunt JI, Young AE, Nunan TO. Misinterpretation of the upper parathyroid adenoma on thallium-201/technetium-99m subtraction scintigraphy. Br J Radiol 1991; 64: 1-4.
25. 99mTc-sestamibi scintigraphy as a first-line imaging procedure in the evaluation of hyperparathyroidism. Clin Endocrinol (Oxf) 1995; 43: 523-524.
26. Földes I, Levay A, Stotz G. Comparative scanning of thyroid nodules with technetium-99m pertechnetate and technetium-99m methoxyisobutylisonitrile. Eur J Nucl Med 1993; 20: 330-333.
27. Billotey C, Aurengo A, Najean Y, et al. Identifying abnormal parathyroid glands in the thyroid uptake area using technetium-99m-sestamibi and factor analysis of dynamic structures. J Nucl Med 1994; 35: 1631-1636.
28. Caravalho J, Balingit AG, Rivera-Rodriguez JE, et al. Localization of an ectopic parathyroid adenoma by double phase technetium-99m-sestamibi scintigraphy. J Nucl Med 1995; 36: 1840-1842.
29. 99mTc-MIBI scintigraphy in localization of abnormal parathyroid glands in hyperparathyroidism. A prospective study. Chirurg 1996; 67: 32-36.
30. Juhlin C, Klareshog C, Nygren P, et al. Hyperparathyroidism is associated with reduced expression of a parathyroid calcium receptor mechanism defined by monoclonal antiparathyroid antibodies. Endocrinology 1988; 122: 2999-3001.
31. Doppman JL. Reoperative parathyroid surgery: localization procedure. Parathyroid surgery. Prog Surg 1986; 18: 117-132.